Congenital disorders of glycosylation: a rapidly expanding disease family.

Congenital disorders of glycosylation (CDG) are a large family of genetic diseases resulting from defects in the synthesis of glycans and in the attachment of glycans to other compounds. These disorders cause a wide range of human diseases, with examples emanating from all medical subspecialties. Since our 2001 review on CDG ( 36 ), this field has seen substantial growth: The number of N-glycosylation defects has doubled (from 6 to 12), five new O-glycosylation defects have been added to the two previously known ones, three combined N- and O-glycosylation defects have been identified, the first lipid glycosylation defects have been discovered, and a new domain, that of the hyperglycosylation defects, has been introduced. A number of CDG are due to defects in enzymes with a putative glycosyltransferase function. There is also a growing group of patients with unidentified defects (CDG-x), some with typical clinical presentations and others with presentations not seen before in CDG. This review focuses on the clinical, biochemical, and genetic characteristics of CDG and on advances expected in their future study and clinical management.

[1]  R. Wevers,et al.  Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups. , 2005, Glycobiology.

[2]  T. Hennet,et al.  Congenital disorder of glycosylation (CDG) Ig: Report on a patient and review of the literature , 2005, Journal of Inherited Metabolic Disease.

[3]  J. Jaeken,et al.  Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. , 2004, Clinical chemistry.

[4]  T. Hennet,et al.  Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency) , 2004, Journal of Medical Genetics.

[5]  H. Freeze.  Update and perspectives on congenital disorders of glycosylation. , 2001, Glycobiology.

[6]  R. Oriol,et al.  Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. , 2005, Blood.

[7]  K. Campbell,et al.  Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies , 2002, Nature.

[8]  K. von Figura,et al.  A New Type of Congenital Disorders of Glycosylation (CDG-Ii) Provides New Insights into the Early Steps of Dolichol-linked Oligosaccharide Biosynthesis* , 2003, Journal of Biological Chemistry.

[9]  G. Hoffmann,et al.  Congenital Disorder of Glycosylation IId (CDG-IId) - A New Entity: Clinical Presentation with Dandy-Walker Malformation and Myopathy , 2002, Neuropediatrics.

[10]  M. Pane,et al.  Expanding the clinical spectrum of POMT1 phenotype , 2006, Neurology.

[11]  H. Freeze.  Congenital Disorders of Glycosylation and the Pediatric Liver , 2001, Seminars in liver disease.

[12]  J. Jaeken,et al.  Congenital disorders of glycosylation: a booming chapter of pediatrics. , 2004, Current opinion in pediatrics.

[13]  I. Dianzani,et al.  Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family , 2006, Journal of Clinical Pathology.

[14]  R. Roberto,et al.  Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes. , 2003, Blood cells, molecules & diseases.

[15]  T. Hennet,et al.  CDG‐IL: An infant with a novel mutation in the ALG9 gene and additional phenotypic features , 2005, American journal of medical genetics. Part A.

[16]  T. Hennet,et al.  The galactosyltransferase family , 2002, Cellular and Molecular Life Sciences CMLS.

[17]  S. Kornfeld,et al.  COG-7-deficient Human Fibroblasts Exhibit Altered Recycling of Golgi Proteins. , 2006, Molecular biology of the cell.

[18]  R. Wevers,et al.  Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder , 2005, Journal of Inherited Metabolic Disease.

[19]  R. Houlston,et al.  Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency , 2006, Nature Medicine.

[20]  M. Huynen,et al.  POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome , 2005, Journal of Medical Genetics.

[21]  J. Jaeken,et al.  Congenital disorders of glycosylation: the rapidly growing tip of the iceberg , 2001, Current opinion in neurology.

[22]  R. Dwek,et al.  Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. , 2003, Glycobiology.

[23]  Ulrich Wagner,et al.  Genome‐wide analysis of the unfolded protein response in fibroblasts from congenital disorders of glycosylation type‐I patients , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  D. Sillence,et al.  Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype. , 2006, American journal of human genetics.

[25]  J. Marth,et al.  A genetic approach to Mammalian glycan function. , 2003, Annual review of biochemistry.

[26]  E. Berger,et al.  ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg. , 2002, Human molecular genetics.

[27]  H. Freeze,et al.  Deficiency of UDP‐GlcNAc:Dolichol Phosphate N‐Acetylglucosamine‐1 Phosphate Transferase (DPAGT1) Causes a Novel Congenital Disorder of Glycosylation Type Ij , 2003, Human mutation.

[28]  R. Rossi,et al.  Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I. , 2004, American journal of human genetics.

[29]  K. Mills,et al.  Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx , 2003, Journal of Inherited Metabolic Disease.

[30]  Ron A Wevers,et al.  A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement: the biochemical characteristics. , 2005, Biochimica et biophysica acta.

[31]  C. Walsh,et al.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. , 2002, American journal of human genetics.

[32]  E. Mayatepek,et al.  A New Subtype of a Congenital Disorder of Glycosylation (CDG) with Mild Clinical Manifestations , 2001, Neuropediatrics.

[33]  M. Boyer,et al.  Hypotrophie et manifestations digestives des désordres congénitaux de la glycosylation , 2003 .

[34]  P. Codogno,et al.  Congenital Disorders of Glycosylation Type Ig Is Defined by a Deficiency in Dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl Mannosyltransferase* , 2002, The Journal of Biological Chemistry.

[35]  Susan C. Brown,et al.  Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. , 2001, American journal of human genetics.

[36]  J. Jaeken.  Congenital disorders of glycosylation (CDG): Update and new developments , 2004, Journal of Inherited Metabolic Disease.

[37]  G. Hoffmann,et al.  A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy , 2002, Journal of Inherited Metabolic Disease.

[38]  R. Hennekam,et al.  Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. , 2006, American journal of human genetics.

[39]  E. Berger,et al.  Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. , 2002, The Journal of clinical investigation.

[40]  Guillaume Vogt,et al.  Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations , 2005, Nature Genetics.

[41]  G. Matthijs,et al.  The prenatal diagnosis of congenital disorders of glycosylation (CDG) , 2004, Prenatal diagnosis.

[42]  H. Freeze,et al.  Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology. , 2005, The Journal of pediatrics.

[43]  J. Jaeken,et al.  Congenital disorders of glycosylation (CDG): It's all in it! , 2003, Journal of Inherited Metabolic Disease.

[44]  H. Freeze,et al.  Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig. , 2005, Molecular genetics and metabolism.

[45]  D. Behar,et al.  Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders , 2005, Journal of Molecular Medicine.

[46]  E. Berger,et al.  Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. , 2004, American journal of human genetics.

[47]  M. Econs,et al.  A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. , 2005, The Journal of clinical endocrinology and metabolism.

[48]  O. Bohorov,et al.  Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder , 2004, Nature Medicine.

[49]  W. Tanner,et al.  Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases. , 2006, Angewandte Chemie.

[50]  G. Matthijs,et al.  Congenital Disorders of Glycosylation (CDG): Update and Perspectives , 2006 .

[51]  C. Gravier-Pelletier,et al.  Mono, di and tri-mannopyranosyl phosphates as mannose-1-phosphate prodrugs for potential CDG-Ia therapy. , 2007, Bioorganic & medicinal chemistry letters.

[52]  G. Matthijs,et al.  Annals of the New York Academy of Sciences Congenital Disorders of Glycosylation , 2022 .

[53]  Peter Walter,et al.  Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein , 2002, Nature.

[54]  H. Topaloglu,et al.  An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker–Warburg syndrome (WWS) caused by a mutation in the POMT1 gene , 2005, Neuromuscular Disorders.

[55]  M. Econs,et al.  Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene. , 2006, The Journal of clinical endocrinology and metabolism.

[56]  J. Marth,et al.  Glycosylation in Cellular Mechanisms of Health and Disease , 2006, Cell.

[57]  J. Denecke,et al.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies , 2003, European Journal of Pediatrics.

[58]  K. von Figura,et al.  Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. , 2004, American journal of human genetics.

[59]  R. Wevers,et al.  Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. , 2003, Clinical chemistry.

[60]  F. Hanefeld,et al.  Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig. , 2002, The Biochemical journal.

[61]  N. Callewaert,et al.  Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Leroy,et al.  Congenital Disorders of N-Glycosylation Including Diseases Associated With O- as Well as N-Glycosylation Defects , 2006, Pediatric Research.

[63]  H. Freeze,et al.  Clinical and biochemical characterization of a patient with congenital disorder of glycosylation (CDG) IIx. , 2005, The Journal of pediatrics.

[64]  H. Freeze,et al.  Extension of lipid-linked oligosaccharides is a high-priority aspect of the unfolded protein response: endoplasmic reticulum stress in Type I congenital disorder of glycosylation fibroblasts. , 2002, Glycobiology.

[65]  M. Mizuno,et al.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. , 2001, Developmental cell.

[66]  H. Freeze.  Human disorders in N-glycosylation and animal models. , 2002, Biochimica et biophysica acta.

[67]  R. Wevers,et al.  Defective protein glycosylation in patients with cutis laxa syndrome , 2005, European Journal of Human Genetics.

[68]  Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts. , 2005, Glycobiology.

[69]  Susan C. Brown,et al.  Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. , 2003, Human molecular genetics.

[70]  E. Berger,et al.  Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. , 2004, Human molecular genetics.

[71]  Markus Aebi,et al.  Altered glycan structures: the molecular basis of congenital disorders of glycosylation. , 2005, Current opinion in structural biology.

[72]  M. Indelman,et al.  Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred , 2006, Journal of Human Genetics.

[73]  H. Freeze,et al.  Cryptogenic Liver Disease in Four Children: A Novel Congenital Disorder of Glycosylation , 2006, Pediatric Research.

[74]  D. Behar,et al.  Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis , 2004, Nature Genetics.

[75]  P. Codogno,et al.  A Deficiency in Dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl α3-Glucosyltransferase Defines a New Subtype of Congenital Disorders of Glycosylation* , 2003, The Journal of Biological Chemistry.

[76]  R. Dwek,et al.  Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase , 2004, Nature Genetics.

[77]  G. Matthijs,et al.  Congenital Disorders of Glycosylation: A Review , 2002, Pediatric Research.

[78]  M. Aebi,et al.  The dolichol pathway of N-linked glycosylation. , 1999, Biochimica et biophysica acta.

[79]  J. Jaeken,et al.  CDG IIx with unusual phenotype , 2004, Journal of Inherited Metabolic Disease.